Global Blood Glucose Measurement Market, 2012-2023

January 2018 | 197 pages | ID: GD155737907EN
Precision Business Insights (PBI)

Abstracts

Blood Glucose Measurement Market

Diabetes mellitus is group of diseases which affects blood sugar (glucose) levels in the body. Glucose is very important for the health as it’s a vital energy source of the cells which is helpful to build the muscles and tissues. It is one of the source to fuel the brain activities. Diabetes is characterised by increased levels of glucose in the blood. Blood glucose measuring devices helps the patients and healthcare professionals in measuring the glucose levels in the blood.

Blood glucose monitoring devices market is driven by the high incidence of diabetes worldwide. According to the World Health Organisation (WHO), prevalence of the diabetes among adults about 18 years, risen from 4.7% to 8.5% from2012 to 2014 and diabetes is the 7th leading cause of the death. In addition to this factors, rise in advancements in technology like evolution in the continuous glucose monitoring devices are boosting the growth of blood glucose monitoring devices market. Moreover, rise in demand of portable self-glucose measuring devices, rise in investments and activities in R&D and funds from the government in preventing and treating diabetes are boosting the growth of the blood glucose measurement devices. Frequent product recalls of glucose testing strips owing to the manufactural defects and supplying of test strips which are, less differentiation products among the self-blood glucose monitors are some of the factors which are hampering the growth of the blood glucose measurement devices. Due to limited facilities of reimbursement and availability of alternative treatments which includes cell based assays, identification of biomarkers and artificial pancreas and high costs of the devices are the few threats for the growth of market.

Global blood glucose measurement device market is segmented based upon product and end-user

By product, blood glucose measurement devices are segmented into

• Self-Glucose Measurement Devices
• Blood Glucose Meter
• Blood Glucose Testing Strips
• Lancets
• Others
• Continuous Glucose Measurement Devices

By end-user, glucose measurement devices market is segmented into

• Hospitals
• Diagnostic Centres
• Home Settings
• Others

Market players are investing heavily to innovate products in order to succour their position in the market, acquisitions and collaborations are the key strategies are used by the market players in order to increase the market share of the companies. For example, in 2017, Abbott Laboratories entered an agreement with Bigfoot Biomedical to commercialize and develop the diabetes management systems and also a Switzerland based company Ascensia Diabetes Care entered partnership with Medtronic to develop and market the diabetes management solutions.

Geographically blood glucose measurement market is divided into five key regions Asia- Pacific, North America, Middle East & Africa, Europe and Latin America. North America expected to be the leader in blood glucose measurement market and expected to have a significant growth rate during the forecast period. Europe region is also expected to show a notable rate of growth due to the changes in lifestyle and rise in adaption of home care diagnosis. Asia-Pacific region due to growing awareness about diabetes consequences like cardiac related issues are contributing the regions to show a significant growth. Initiatives taken by the government and non-government organizations in order to spread the awareness about the early diagnosis of diabetes, changes in lifestyle, large pool of patients are expected to drive the blood glucose measurement market growth.

Some of the players in the blood glucose measurement market are Nipro Diagnostics, Inc. (U.S.), Abbott Laboratories (U.S.), ARKRAY (Japan), Medtronic (U.S.), Bayer AG (Germany), Dexcom, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson and Johnson Services Inc. (U.S.) and Terumo Medical Corporation (U.S.) to name a few.

In 2016, Roche launched the Accu-Chek® Guide, the next-gen blood glucose monitoring system

In 2013, a Norway based manufacturer Prediktor Medical, developed a wearable device for estimating the blood glucose levels with dynamic models advanced and multivariate analysis and for interaction of insulin or glucose

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET INTRODUCTION

2.1. Global Blood Glucose Measurement Devices Market – Taxonomy
2.2. Global Blood Glucose Measurement Devices Market –Definitions
  2.2.1. Device Type
  2.2.2. End User

3. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Blood Glucose Measurement Devices Market Dynamic Factors - Impact Analysis

4. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET, BY DEVICE TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. Self-Glucose Measurement Devices
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Continuous Glucose Measurement Devices
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

6.1. Hospitals
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Diagnostic Centers
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Home Settings
  6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Others
  6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis

7. GLOBAL BLOOD GLUCOSE MEASUREMENT DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

7.1. North America
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Region, 2017 – 2023

8. NORTH AMERICA BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.1.1. Self-Glucose Measurement Devices
    8.1.1.1. Blood Glucose Meter
    8.1.1.2. Blood Glucose Testing Strips
    8.1.1.3. Lancets
    8.1.1.4. Others
  8.1.2. Continuous Glucose Measurement Devices
8.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  8.2.1. Hospitals
  8.2.2. Diagnostic Centres
  8.2.3. Home Settings
  8.2.4. Others
8.3. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  8.3.1. U.S.
  8.3.2. Canada
8.4. North America Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
8.5. North America Blood Glucose Measurement Devices Market Dynamics – Trends

9. EUROPE BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Self-Glucose Measurement Devices
    9.1.1.1. Blood Glucose Meter
    9.1.1.2. Blood Glucose Testing Strips
    9.1.1.3. Lancets
    9.1.1.4. Others
  9.1.2. Continuous Glucose Measurement Devices
9.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.2.1. Hospitals
  9.2.2. Diagnostic Centres
  9.2.3. Home Settings
  9.2.4. Others
9.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Germany
  9.3.2. UK
  9.3.3. France
  9.3.4. Spain
  9.3.5. Italy
  9.3.6. Russia
  9.3.7. Poland
  9.3.8. Rest of Europe
9.4. Europe Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
9.5. Europe Blood Glucose Measurement Devices Market Dynamics – Trends

10. ASIA-PACIFIC BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Self-Glucose Measurement Devices
    10.1.1.1. Blood Glucose Meter
    10.1.1.2. Blood Glucose Testing Strips
    10.1.1.3. Lancets
    10.1.1.4. Others
  10.1.2. Continuous Glucose Measurement Devices
10.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Hospitals
  10.2.2. Diagnostic Centres
  10.2.3. Home Settings
  10.2.4. Others
10.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Japan
  10.3.2. China
  10.3.3. India
  10.3.4. ASEAN
  10.3.5. Australia & New Zealand
  10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
10.5. Asia-Pacific Blood Glucose Measurement Devices Market Dynamics – Trends

11. LATIN AMERICA BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Self-Glucose Measurement Devices
    11.1.1.1. Blood Glucose Meter
    11.1.1.2. Blood Glucose Testing Strips
    11.1.1.3. Lancets
    11.1.1.4. Others
  11.1.2. Continuous Glucose Measurement Devices
11.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Hospitals
  11.2.2. Diagnostic Centres
  11.2.3. Home Settings
  11.2.4. Others
11.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Brazil
  11.3.2. Mexico
  11.3.3. Argentina
  11.3.4. Venezuela
  11.3.5. Rest of Latin America
11.4. Latin America Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
11.5. Latin America Blood Glucose Measurement Devices Market Dynamics – Trends

12. MIDDLE EAST AND AFRICA BLOOD GLUCOSE MEASUREMENT DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Device Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Self-Glucose Measurement Devices
    12.1.1.1. Blood Glucose Meter
    12.1.1.2. Blood Glucose Testing Strips
    12.1.1.3. Lancets
    12.1.1.4. Others
  12.1.2. Continuous Glucose Measurement Devices
12.2. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Hospitals
  12.2.2. Diagnostic Centres
  12.2.3. Home Settings
  12.2.4. Others
12.3. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Gulf Cooperation Council (GCC) Countries
  12.3.2. Israel
  12.3.3. South Africa
  12.3.4. Rest of MEA
12.4. MEA Blood Glucose Measurement Devices Market - Opportunity Analysis Index, By Device Type, By End User, and Country, 2017 – 2023
12.5. MEA Blood Glucose Measurement Devices Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Nipro Diagnostics, Inc. (U.S.)
  13.2.2. Abbott Laboratories (U.S.)
  13.2.3. ARKRAY (Japan)
  13.2.4. Medtronic (U.S.)
  13.2.5. Bayer AG (Germany)
  13.2.6. Dexcom, Inc. (U.S.)
  13.2.7. F. Hoffmann-La Roche Ltd (Switzerland)
  13.2.8. Johnson and Johnson Services Inc. (U.S.)
  13.2.9. Terumo Medical Corporation (U.S.)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS